JP2008540603A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008540603A5 JP2008540603A5 JP2008511670A JP2008511670A JP2008540603A5 JP 2008540603 A5 JP2008540603 A5 JP 2008540603A5 JP 2008511670 A JP2008511670 A JP 2008511670A JP 2008511670 A JP2008511670 A JP 2008511670A JP 2008540603 A5 JP2008540603 A5 JP 2008540603A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- gel
- acid
- methoxydiphenylpropenoic
- adamantylmethoxydiphenylpropenoic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims 1
- 208000002874 Acne Vulgaris Diseases 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 206010000496 acne Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- -1 adamantyl methoxydiphenylpropenoic acid Chemical compound 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 claims 1
- 229940067606 lecithin Drugs 0.000 claims 1
- 235000010445 lecithin Nutrition 0.000 claims 1
- 239000000787 lecithin Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITRM2005A000248 | 2005-05-20 | ||
| IT000248A ITRM20050248A1 (it) | 2005-05-20 | 2005-05-20 | Uso acido adamantil metossidifenil propenoico per il trattamento di patologie cutanee. |
| PCT/EP2006/062088 WO2006122883A1 (en) | 2005-05-20 | 2006-05-05 | Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008540603A JP2008540603A (ja) | 2008-11-20 |
| JP2008540603A5 true JP2008540603A5 (enExample) | 2009-07-02 |
| JP5072833B2 JP5072833B2 (ja) | 2012-11-14 |
Family
ID=36646157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008511670A Expired - Fee Related JP5072833B2 (ja) | 2005-05-20 | 2006-05-05 | ざ瘡の治療のためのアダマンチルメトキシジフェニルプロペン酸の使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7635719B2 (enExample) |
| EP (1) | EP1890671B1 (enExample) |
| JP (1) | JP5072833B2 (enExample) |
| KR (1) | KR101307910B1 (enExample) |
| CN (1) | CN101180028B (enExample) |
| AR (1) | AR054361A1 (enExample) |
| AU (1) | AU2006248981B2 (enExample) |
| BR (1) | BRPI0611289A2 (enExample) |
| CA (1) | CA2606567A1 (enExample) |
| IT (1) | ITRM20050248A1 (enExample) |
| MX (1) | MX2007014222A (enExample) |
| TW (1) | TWI365753B (enExample) |
| WO (1) | WO2006122883A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5109383B2 (ja) * | 2007-01-31 | 2012-12-26 | 大正製薬株式会社 | アダパレン含有外用剤組成物 |
| JP2009137874A (ja) * | 2007-12-05 | 2009-06-25 | Authele:Kk | ビタミンＣ（Ａｓｃｏｒｂｉｃａｃｉｄ）を含有するレシチンゲルおよびその製造方法 |
| TW201031402A (en) * | 2008-12-24 | 2010-09-01 | Sigma Tau Ind Farmaceuti | New retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties |
| EP3301085A1 (en) * | 2016-09-29 | 2018-04-04 | Biogem S.Ca.R.L. | Retinoid derivatives with antitumor activity |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6071923A (en) * | 1994-09-16 | 2000-06-06 | Bar-Ilan University | Retinoyloxy aryl-substituted alkylene butyrates useful for the treatment of cancer and other proliferative diseases |
| FR2752734B1 (fr) * | 1996-09-02 | 1998-11-06 | Cird Galderma | Utilisation de retinoides pour la preparation d'un medicament destine a traiter les affections liees a une surexpression de vegf |
| US5994330A (en) * | 1998-11-09 | 1999-11-30 | El Khoury; Georges F. | Topical application of muscarinic agents such as neostigmine for treatment of acne and other inflammatory conditions |
| ITRM20010464A1 (it) * | 2001-07-31 | 2003-01-31 | Sigma Tau Ind Farmaceuti | Derivati retinoidi ad attivita' antiangiogenica, antitumorale e pro-apoptotica. |
| SI1485080T1 (sl) * | 2002-03-12 | 2009-10-31 | Galderma Res & Dev | Uporaba adapalena za zdravljenje dermatoloških motenj |
-
2005
- 2005-05-20 IT IT000248A patent/ITRM20050248A1/it unknown
-
2006
- 2006-05-03 TW TW095115754A patent/TWI365753B/zh not_active IP Right Cessation
- 2006-05-05 MX MX2007014222A patent/MX2007014222A/es active IP Right Grant
- 2006-05-05 JP JP2008511670A patent/JP5072833B2/ja not_active Expired - Fee Related
- 2006-05-05 CA CA002606567A patent/CA2606567A1/en not_active Abandoned
- 2006-05-05 CN CN2006800175175A patent/CN101180028B/zh not_active Expired - Fee Related
- 2006-05-05 US US11/911,749 patent/US7635719B2/en not_active Expired - Fee Related
- 2006-05-05 KR KR1020077027137A patent/KR101307910B1/ko not_active Expired - Fee Related
- 2006-05-05 BR BRPI0611289-7A patent/BRPI0611289A2/pt not_active IP Right Cessation
- 2006-05-05 EP EP06755041.8A patent/EP1890671B1/en active Active
- 2006-05-05 AU AU2006248981A patent/AU2006248981B2/en not_active Ceased
- 2006-05-05 WO PCT/EP2006/062088 patent/WO2006122883A1/en not_active Ceased
- 2006-05-17 AR ARP060101983A patent/AR054361A1/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2409069B2 (es) | Uso de aglutinantes para fabricar formulaciones estables al almacenamiento | |
| JP2010535814A5 (enExample) | ||
| JP2009500443A5 (enExample) | ||
| JP2015524444A5 (enExample) | ||
| WO2008157103A3 (en) | Modified release solid or semi-solid dosage forms | |
| EP2444072A3 (en) | Non-mucoadhesive film dosage forms | |
| JP2005512997A5 (enExample) | ||
| WO2008008397A3 (en) | Fatty acid pharmaceutical foam | |
| WO2008064192A3 (en) | Modified release analgesic suspensions | |
| JP2012515184A5 (enExample) | ||
| NZ605469A (en) | Nalbuphine-based formulations and uses thereof | |
| JP2012517449A5 (enExample) | ||
| JP2007523135A5 (enExample) | ||
| JP2009537554A5 (enExample) | ||
| WO2017182873A3 (en) | Peptide-oligourea foldamer compounds and methods of their use | |
| NZ591408A (en) | Paracetamol and Calcium carbonate composition | |
| WO2007014124A3 (en) | High drug load formulations and dosage forms | |
| JP2007238598A5 (enExample) | ||
| JP2007119497A5 (enExample) | ||
| JP2013543518A5 (enExample) | ||
| JP2008540603A5 (enExample) | ||
| AR059225A1 (es) | Sal de citrato, proceso de preparacion y su actividad en terapia | |
| WO2006088945A3 (en) | Granulysin peptides and methods of use thereof | |
| JP2010524906A5 (enExample) | ||
| EA201290378A1 (ru) | Композиции, содержащие нестероидные противовоспалительные лекарственные средства |